FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Dexilant (lansoprazole) from Takeda Pharmaceuticals America, expanding its labeling and indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexilant (dexlansoprazole)

Snippet

SUPPL AP for DEXILANT (DEXLANSOPRAZOLE)